The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Hydroxocobalamin Basi 1000 microgram/mL solution for injection

Phoenix LabsPA1113/031/001

Main Information

Trade NameHydroxocobalamin Basi 1000 microgram/mL solution for injection
Active SubstancesHydroxocobalamin chloride
Dosage FormSolution for injection
Licence HolderPhoenix Labs
Licence NumberPA1113/031/001

Group Information

ATC CodeB03BA03 hydroxocobalamin


License statusAuthorised
Licence Issued24/03/2023
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0121-172-063
Interchangeable List DocumentPDF of Interchangeable List
« Back